Literature DB >> 10885465

Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum.

T Kiss1, E Kiss, E Garribba, H Sakurai.   

Abstract

The biospeciations of three potential insulin-mimetic VO(IV) compounds, VO(maltolate)2, VO(picolinate)2 and VO(6-Me-picolinate)2, in blood serum were assessed via modelling calculations, using the stability constants reported in the literature for the binary insulin-mimetic complexes and their ternary complexes formed with the most important low molecular mass binders in the serum: oxalic acid, lactic acid, citric acid and phosphate. The binding capabilities of two high molecular mass serum proteins, albumin and transferrin, were also taken into account.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885465     DOI: 10.1016/s0162-0134(00)00041-6

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  12 in total

Review 1.  Vanadium in Biosphere and Its Role in Biological Processes.

Authors:  Deepika Tripathi; Veena Mani; Ravi Prakash Pal
Journal:  Biol Trace Elem Res       Date:  2018-03-09       Impact factor: 3.738

2.  Binding of V(IV)O²⁺ to the Fe binding sites of human serum transferrin. A theoretical study.

Authors:  Gonçalo C Justino; Eugenio Garribba; João Costa Pessoa
Journal:  J Biol Inorg Chem       Date:  2013-10       Impact factor: 3.358

3.  A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds.

Authors:  Daniele Sanna; Péter Buglyó; Giovanni Micera; Eugenio Garribba
Journal:  J Biol Inorg Chem       Date:  2010-03-26       Impact factor: 3.358

4.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

Review 5.  The thermodynamics of protein interactions with essential first row transition metals.

Authors:  Fadi Bou-Abdallah; Thomas R Giffune
Journal:  Biochim Biophys Acta       Date:  2015-11-10

6.  Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.

Authors:  Hiroyuki Yasui; Yusuke Adachi; Akira Katoh; Hiromu Sakurai
Journal:  J Biol Inorg Chem       Date:  2007-05-15       Impact factor: 3.358

7.  Coordinative interaction of microcrystalline chitosan with oxovanadium (IV) ions in aqueous solution.

Authors:  Marta E Lichawska; Kazimiera H Bodek; Julia Jezierska; Aleksander Kufelnicki
Journal:  Chem Cent J       Date:  2014-09-09       Impact factor: 4.215

Review 8.  Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.

Authors:  Agnieszka Ścibior; Łukasz Pietrzyk; Zbigniew Plewa; Andrzej Skiba
Journal:  J Trace Elem Med Biol       Date:  2020-04-12       Impact factor: 3.849

9.  Vanadyl sulfate treatment stimulates proliferation and regeneration of beta cells in pancreatic islets.

Authors:  Samira Missaoui; Khémais Ben Rhouma; Mohamed-Tahar Yacoubi; Mohsen Sakly; Olfa Tebourbi
Journal:  J Diabetes Res       Date:  2014-08-19       Impact factor: 4.011

Review 10.  Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.

Authors:  Thomas Scior; Jose Antonio Guevara-Garcia; Quoc-Tuan Do; Philippe Bernard; Stefan Laufer
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.